THE RESULTS: Drug and materials company Bayer AG said its quarterly net income rose 42 percent as sales increased for its new drugs, while one-time expenses dropped.
CURRENCY HIT: Profit rose to 733 million euros ($1.01 billion), while revenue was virtually flat at 9.64 billion euros. The German company said revenue rose 6 percent when stripping out the impact of the euro's recent rise.
DRIVEN BY INNOVATION: The combined sales of new products such as blood thinner Xarelto, macular degeneration drug Eylea, and cancer drugs Stivarga and Xofigo soared to 407 million euros from 82 million euros a year ago.
- Health Care Industry